Cargando…
Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes
Insulin-dependent diabetes mellitus (IDDM) is an autoimmune disease that results in the destruction of the pancreatic islet beta cells. Glutamic acid decarboxylase (GAD) has been recently indicated as a key autoantigen in the induction of IDDM in nonobese diabetic mice. In human diabetes, the mechan...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2191981/ https://www.ncbi.nlm.nih.gov/pubmed/7722468 |
Ejemplares similares
-
Neurological Manifestations of Glutamic Acid Decarboxylase Autoimmunity in Indian Patients
por: Thevarkalam, Meena, et al.
Publicado: (2023) -
Antibodies to Inhibitory Synaptic Proteins in Neurological Syndromes Associated with Glutamic Acid Decarboxylase Autoimmunity
por: Gresa-Arribas, Nuria, et al.
Publicado: (2015) -
Expression of recombinant glutamic acid decarboxylase in insect larvae and its application in an immunoassay for the diagnosis of autoimmune diabetes mellitus
por: Trabucchi, Aldana, et al.
Publicado: (2019) -
Cognitive decline in a patient with anti-glutamic acid decarboxylase autoimmunity; case report
por: Takagi, Masahito, et al.
Publicado: (2011) -
Normal Incidence of Diabetes in NOD Mice Tolerant to Glutamic Acid Decarboxylase
por: Jaeckel, Elmar, et al.
Publicado: (2003)